Heterocycles · 1987 · 19 citations · 0 references
PharmacyChemistryMedicinal ChemistryOrganic ChemistryStructure-activity RelationshipsSynthetic Medicinal ChemistryPhenylpropanoid BiosynthesisRetrosynthetic AnalysisClaisen Rearrangement
The 3-ll',l'-dimethylallyllcoumarins chalepin (21, rutamarin ( 3 ) and gra--v e l l i f e r o n e 141 have been synthesized from umbelliferon ( v i a Claisen and Cope r e - arrangealents of 3 ' , 3 ' -d i m e t h y l a l l y l ethers of 6-(3',3'-dimethylallyllumbelliferon w i t h and without an iodine atonl as blocking group at C-8.Some n a t u r a l d e r i v a t i v e s of 3 -( I ' , l ' -d i m e t h y l a l l y 1 )coumarins have been seen t o have c y t o s t a t i c , sometimes s e l e c t i v e , effects on leukemic c e l l s !" The following compounds have been assayed " i n v i t r o " : chalepensin (11, chalepin (21 and i t s acetate, rutamarin ( 3 ) .As these compounds have been 3obtained i n small q u a n t i t i e s from species o f &, we have undertaken t h e i r synthesis so t h a t they may be obtained i n s u f f i c i e n t q u a n t i t i e s f o r f u r t h e r t h e i r pharmacological study.This paper describes the synthesis o f t h e coumarins 2, 3 and !? i n 7.5 %, 7.0 % and 10.3 % o v e r a l l y i e l d s r e s p e c t i v e l y .The key step involves Claisen and Cope rearrangements of the corresponding 3 ' , 3 ' -d i m e t h y l a l l y 1 ether of 6-(3',3'-dimethylallyllumbelliferon.Our approach took i n t o account the high y i e l d o f compound 5, obtained i n t h e course o f the rearrangement o f 6 from an a l l y l i c ether of urrbelliferon w i t h p o s i t i o n C-6 and C-8 being blocked.As s a t i s f a c t o r y r e s u l t s were n o t obtained w i t h t h i s procedure, the synthesis was undertaken anew w i t h o u t blocking t h e C-8 p o s i t i o n , which gave b e t t e r r e s u l t s . 5Treatment of umbelliferon ( L l w i t h i o d i n e i n ammonia gave 8-iodoumbelliferon (8, 84 %I.A l k y l a t i o n of 1 w i t h 3-chloro-3-methyl-1-butyne gave 7-(1',1'-dimethylpropynyloxyl-8-iodocoumarin (9, 78 %I.9 was hydrogenated on BaS04 -Pd i n toluene, y i e l d i n g 7-(l',la-dimethylally1oxy)-8-iodocouma--5 r i n ( E l .Claisen rearrangement o f 10 i n d i m e t h y l a n i l i n e (MA) a t 150°C gave demethylsuberosin (fl) and os- 5 thenol ( 2 1 i n 70 % and 25 %, respectively.When Claisen rearrangement was c a r r i e d o u t i n AcZO/AcONa 13 (53 %I, 14 (31 %I and 11 (11 %I were obtained.--Treatment o f 13 w i t h 3,3-dimethylallyl bromide, i n t h e presence of KZC03 i n acetone, gave 6 -( 3 ' , 3 'dimethylallyll-7-dimethylallyloxyl-8-iodocoumarin (16, -61 %I.The same compound was obtained by hydrolysis of the acetate (13, 97 %I and f u r t h e r isoprenylation (96 $1 of t h e r e s u l t i n g phenol x.Rearrangement o f 16 i n DMA a t 200°C gave three main products, characterised as g r a v e l l i f e r o n e (4, 10 %I.demethylsuberosin (2, 36 %i and 6-(3',3'-dimethylallyl1-8,9,9-trimethyl-8,9-dihydroangelic i n (16, 36 %I.The H-NMR spectrum o f 2 was very complex, so t h a t i t was i d e n t i f i e d bearing i n 6 mind the r e s u l t s obtained i n the rearrangement of 3',3'-dimethylallylumbelliferon where o n e o f t h e products obtained turned t o be 8,9,9-trimethyl-8,S-dihydroangelicin.I n any case, t h